Compare Stocks

→ Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRTSW Alpha Tau Medical	$0.22 +15.9%	$0.25	$0.14 ▼ $0.45	N/A	N/A	8,076 shs	5,756 shs
MYNZ Mainz Biomed	$0.75 -14.8%	$0.98	$0.74 ▼ $6.00	N/A	0.24	100,216 shs	139,229 shs
TLGT Teligent		$0.03	$0.17 ▼ $1.60	N/A	N/A	N/A	6,460 shs

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRTSW Alpha Tau Medical	+6.10%	-7.45%	-13.07%	-11.73%	-1.18%
MYNZ Mainz Biomed	+1.49%	+1.25%	-14.57%	-9.29%	-76.72%
TLGT Teligent	0.00%	0.00%	0.00%	0.00%	0.00%

The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DRTSW Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MYNZ Mainz Biomed	1.7297 of 5 stars	3.3	4.0	0.0	0.0	1.5	0.0	0.0
TLGT Teligent	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DRTSW Alpha Tau Medical	N/A	N/A	N/A	N/A
MYNZ Mainz Biomed	2.50	Moderate Buy	$6.00	700.00% Upside
TLGT Teligent	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest TLGT, MYNZ, and DRTSW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/12/2024	MYNZ Mainz Biomed	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral
3/6/2024	MYNZ Mainz Biomed	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$5.00 ➝ $3.00

(Data available from 5/1/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DRTSW Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A	N/A
MYNZ Mainz Biomed	$900K	N/A	N/A	N/A	$0.27 per share	N/A
TLGT Teligent	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DRTSW Alpha Tau Medical	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MYNZ Mainz Biomed	-$26.30M	-$1.64	N/A	∞	N/A	-2,934.82%	-488.05%	-145.77%	5/21/2024 (Estimated)
TLGT Teligent	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest TLGT, MYNZ, and DRTSW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/9/2024	Q4 2023	MYNZ Mainz Biomed	N/A	-$0.24	-$0.24	-$0.24	N/A	$0.22 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DRTSW Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
MYNZ Mainz Biomed	N/A	N/A	N/A	N/A	N/A
TLGT Teligent	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DRTSW Alpha Tau Medical	N/A	N/A	N/A
MYNZ Mainz Biomed	0.36	0.97	0.91
TLGT Teligent	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
DRTSW Alpha Tau Medical	N/A
MYNZ Mainz Biomed	N/A
TLGT Teligent	N/A

Insider Ownership

Company	Insider Ownership
DRTSW Alpha Tau Medical	N/A
MYNZ Mainz Biomed	N/A
TLGT Teligent	0.17%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DRTSW Alpha Tau Medical	121	N/A	N/A	Not Optionable
MYNZ Mainz Biomed	65	N/A	N/A	Not Optionable
TLGT Teligent	2,357	N/A	N/A	Optionable

TLGT, MYNZ, and DRTSW Headlines

Source	Headline
	Topical pain reliever recalled for problem that can cause ‘severe morbidity, even death’ charlotteobserver.com - June 7 at 10:18 AM
	β1 Adrenoceptor Agonists Market 2023 Newest Industry Data ... - StreetBuzz news.google.com - May 13 at 1:32 AM
	Lidocaine Ointment Market Upcoming Trends, Size, Key Players ... - Taiwan News news.google.com - May 13 at 1:32 AM
	Global Mobile Value-Added Services (VAS) Industry Market Report ... - Industry Today news.google.com - May 11 at 4:41 AM
	Global Clindamycin Phosphate Topical Market Analysis, Share ... - The Northwestern Examiner news.google.com - May 8 at 10:54 AM
	Dry Skin Treatment Market Products, Share, Types, Applications, Growth, Insights and Forecasts Report to 2028 - openPR news.google.com - May 8 at 5:54 AM
	Mobile Value-Added Services (VAS) Market Size, Growth ... - Digital Journal news.google.com - May 8 at 5:54 AM
	Mobile Value-Added Services (VAS) Market 2023 Global Insights ... - The Northwestern Examiner news.google.com - May 5 at 9:12 AM
	Epinephrine For Allergy Treatment Market Dynamic Growth Factors ... - Digital Journal news.google.com - May 3 at 7:08 AM
	Erythromycin Market with Focus on Growth Analysis, Production ... - Digital Journal news.google.com - May 2 at 8:42 AM
	From 2023 to 2031 Mobile Value-Added Services (VAS) Market ... - Digital Journal news.google.com - April 29 at 8:17 AM
	Tremendous Growth Of Drugs To Relieve Paraneoplastic Pemphigus Market (2023-2030 )Industry Insights, SWOT Anal - openPR news.google.com - April 28 at 10:17 PM
	Drugs to Relieve Paraneoplastic Pemphigus Market 2023 Provides Top Companies Data, Top Key Players, Types and - openPR news.google.com - April 26 at 1:32 PM
	Topical Drug Delivery Market Production Capacity Estimates, Industry Size, Current Trend, Competition, Growth, - openPR news.google.com - April 26 at 8:32 AM
	Triamcinolone Market \| Driving Factors, Industry Analysis ... - Taiwan News news.google.com - April 24 at 4:23 PM
	IDT Corp. Cl B wsj.com - April 23 at 2:59 AM
	Mobile Value-Added Services (VAS) Markets edge up Strategic ... - Digital Journal news.google.com - April 17 at 2:17 PM
	Hikma Names Injectables Chief Mishlawi As CEO - Generics Bulletin news.google.com - April 12 at 1:13 PM
	Mobile Value-Added Services (VAS) Market is Anticipated to Shown ... - Digital Journal news.google.com - April 10 at 1:16 PM
	Everstream Names Ken Fitzpatrick as President and Chief Executive ... - Joplin Globe news.google.com - April 6 at 1:58 PM
	Lidocaine Ointment Market Growth Till, 2023-2030: Coherent Market ... - Digital Journal news.google.com - March 29 at 7:08 AM
	Mobile Value-Added Services (VAS) Maket Is Set to Fly High in ... - Digital Journal news.google.com - March 29 at 2:07 AM
	Gonorrhea Treatment Market Size 2023 - Current Sales Analysis, Upcoming Trends, Opportunities, Development His - openPR news.google.com - March 28 at 10:26 AM
	Bankruptcy Standing: An Introduction to a Multitude \| Reed Smith ... - JD Supra news.google.com - March 25 at 8:59 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alpha Tau Medical

NASDAQ:DRTSW

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Mainz Biomed

NASDAQ:MYNZ

Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.

Teligent

NASDAQ:TLGT

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial